---
title: "Sinovac's combined hepatitis A and B vaccine, Beirlaifu, is re-registered for market launch"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250957732.md"
description: "Beijing Kexing Holdings Co., Ltd. subsidiary Beijing Kexing Biological Products Co., Ltd. independently developed the combined hepatitis A and B vaccine Beirlaifu, which has obtained the drug re-registration approval notice, making it the only combined hepatitis A and B vaccine approved for market in China"
datetime: "2025-07-31T09:36:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250957732.md)
  - [en](https://longbridge.com/en/news/250957732.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250957732.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/250957732.md) | [繁體中文](https://longbridge.com/zh-HK/news/250957732.md)


# Sinovac's combined hepatitis A and B vaccine, Beirlaifu, is re-registered for market launch

Beijing Kexing Holdings Co., Ltd. subsidiary Beijing Kexing Biological Products Co., Ltd. independently developed the combined hepatitis A and B vaccine Beirlaifu, which has obtained the drug re-registration approval notice, making it the only combined hepatitis A and B vaccine approved for sale in China

### Related Stocks

- [Sinobioway Medicine (002581.CN)](https://longbridge.com/en/quote/002581.CN.md)

## Related News & Research

- [Tennis-Swiatek, Gauff inspired by figure skater Liu's journey from teen burnout to Olympic gold](https://longbridge.com/en/news/277736403.md)
- [Sino Biopharm Unit Signs Global License Deal With Sanofi for Rovadicitinib](https://longbridge.com/en/news/277705715.md)
- [EXCLUSIVE-US postpones third consecutive meeting of preventive health panel](https://longbridge.com/en/news/277672116.md)
- [Measles cases rise by 5 to 990, state health department says](https://longbridge.com/en/news/277664664.md)
- [13:50 ETNejvětší farmaceutický veletrh v Asii se v červnu 2026 vrátí do Šanghaje](https://longbridge.com/en/news/277666717.md)